CDC123 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.404400E-01
Normal-vs-Stage2
8.143200E-01
Normal-vs-Stage3
5.666200E-01
Normal-vs-Stage4
9.535800E-01
Stage1-vs-Stage2
8.326200E-01
Stage1-vs-Stage3
7.058400E-01
Stage1-vs-Stage4
6.235400E-01
Stage2-vs-Stage3
5.115400E-01
Stage2-vs-Stage4
7.416000E-01
Stage3-vs-Stage4
5.322200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.065000E-01
Normal-vs-AfricanAmerican
7.812000E-01
Normal-vs-Asian
3.333600E-01
Caucasian-vs-AfricanAmerican
9.699800E-01
Caucasian-vs-Asian
2.065000E-01
AfricanAmerican-vs-Asian
3.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.703000E-01
Normal-vs-Female
8.790800E-01
Male-vs-Female
4.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.204200E-01
Normal-vs-Age(41-60Yrs)
9.907600E-01
Normal-vs-Age(61-80Yrs)
6.380400E-01
Normal-vs-Age(81-100Yrs)
7.466800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.119800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.961400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.555800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.165900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.350000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.348500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.873200E-01
Normal-vs-Daily Drinker
8.077600E-01
Normal-vs-Weekly Drinker
9.128400E-01
Normal-vs-Occasional Drinker
8.651400E-01
Normal-vs-Social Drinker
3.813200E-01
Non Drinker-vs-Daily Drinker
7.023000E-01
Non Drinker-vs-Weekly Drinker
3.702600E-01
Non Drinker-vs-Occasional Drinker
5.273800E-01
Non Drinker-vs-Social Drinker
7.638800E-01
Daily Drinker-vs-Weekly Drinker
5.555000E-01
Daily Drinker-vs-Occasional Drinker
8.037200E-01
Daily Drinker-vs-Social Drinker
5.132000E-01
Weekly Drinker-vs-Occasional Drinker
6.891000E-01
Weekly Drinker-vs-Social Drinker
3.036200E-01
Occasional Drinker-vs-Social Drinker
2.798800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.210600E-01
Normal-vs-Grade 2
7.801600E-01
Normal-vs-Grade 3
7.913800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.199620E-02
Grade 1-vs-Grade 3
4.263500E-02
Grade 1-vs-Grade 4
9.210600E-01
Grade 2-vs-Grade 3
8.079400E-01
Grade 2-vs-Grade 4
7.801600E-01
Grade 3-vs-Grade 4
7.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.836400E-01
Normal-vs-NonDiabetic
7.464000E-01
Diabetic-vs-NonDiabetic
8.703600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.395600E-01
Normal-vs-NoPancreatitis
7.606800E-01
Pancreatitis-vs-NoPancreatitis
9.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.740600E-01
Normal-vs-N1
8.334800E-01
N0-vs-N1
7.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.107400E-01
Normal-vs-TP53-NonMutant
6.390400E-01
TP53-Mutant-vs-TP53-NonMutant
2.037000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
